Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3655023014 | Prolonged-release vaginal ring | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3655024015 | Prolonged-release vaginal ring (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prolonged-release vaginal ring | Is a | Vaginal dose form (dose form) | true | Inferred relationship | Some | ||
| Prolonged-release vaginal ring | Has dose form administration method (attribute) | Insert (administration method) | true | Inferred relationship | Some | ||
| Prolonged-release vaginal ring | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some | ||
| Prolonged-release vaginal ring | Has dose form intended site (attribute) | Vaginal | true | Inferred relationship | Some | ||
| Prolonged-release vaginal ring | Has dose form release characteristic (attribute) | Prolonged-release (release characteristic) | true | Inferred relationship | Some | ||
| Prolonged-release vaginal ring | Has basic dose form (attribute) | Ring | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | True | Prolonged-release vaginal ring | Inferred relationship | Some | |
| Estradiol 4.167 microgram/hour prolonged-release vaginal ring | Has manufactured dose form | True | Prolonged-release vaginal ring | Inferred relationship | Some | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | True | Prolonged-release vaginal ring | Inferred relationship | Some | |
| Progesterone 416.667 microgram/hour prolonged-release vaginal ring | Has manufactured dose form | True | Prolonged-release vaginal ring | Inferred relationship | Some |
This concept is not in any reference sets
FHIR